Xenon Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It develops therapeutics to improve the lives of patients with neurological disorders, including rare central nervous system (CNS) conditions. The company's products include XEN496, XEN1101, XEN901 and XEN007. Xenon Pharmaceuticals was founded by Simon Neil Pimstone, Johannes J. P. Kastelein and Michael R. Hayden on November 5, 1996 and is headquartered in Burnaby, Canada.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
327
Frequently Asked Questions
What is Market Cap of Xenon Pharmaceuticals Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Xenon Pharmaceuticals Inc market cap is $3.02B.
What is the 52-week high for Xenon Pharmaceuticals Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Xenon Pharmaceuticals Inc 52 week high is $46.00 as of October 03, 2025.
What is the 52-week low for Xenon Pharmaceuticals Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Xenon Pharmaceuticals Inc 52 week low is $26.74 as of October 03, 2025.
What is Xenon Pharmaceuticals Inc stock price today?
Xenon Pharmaceuticals Inc stock price today is $39.48.
What was Xenon Pharmaceuticals Inc stock price yesterday?
Xenon Pharmaceuticals Inc stock price yesterday was $39.20.
What is the PE ratio of Xenon Pharmaceuticals Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Xenon Pharmaceuticals Inc’s P/E ratio is -11.06.
What is the Price-to-Book ratio of Xenon Pharmaceuticals Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Xenon Pharmaceuticals Inc P/B ratio is 4.7573.
What is the 50-day moving average of Xenon Pharmaceuticals Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Xenon Pharmaceuticals Inc 50-day moving average is $36.38.
How many employess does Xenon Pharmaceuticals Inc has?